Cencora Inc (COR) News & Events

$340.920

-0.477 (-0.14%)At close

COR News

9.510-02Newsfilter

Cencora to Release Q4 Fiscal 2026 Results on November 4, 2026

5.009-25Newsfilter

Cencora Appoints New Independent Director

6.509-10CNBC

Jim Cramer Highlights Six Stocks to Buy Now

6.508-29Yahoo Finance

Comparing AbbVie and Johnson & Johnson for Investment

4.008-19Fool

Investment Opportunities Amid Trumpflation

2.008-12Yahoo Finance

Cencora Discloses Changes in Walgreens Volume

9.508-10CNBC

Key Highlights from Monday's Investing Club Meeting

9.508-09CNBC

Inflation Data and Market Dynamics Preview

4.508-07CNBC

Market Update: Stocks Rise Ahead of Record Close

9.508-05seekingalpha

Cencora Q3 Earnings: EPS Guidance Raised Amid Strong Performance

Show More News

COR Events

9/25 08:30

Cencora Appoints Robert Sanchez as Independent Director

Cencora announced that its Board of Directors has elected Robert Sanchez as a new independent director, effective October 1. Sanchez is the Executive Chair of Ryder System, Inc., where he previously served as Chair and CEO until his retirement in March.

8/31 10:30

Trump Says Anti-Data Center Movement Will Lead to Poverty

President Trump said via Truth Social that, "The only reason that communities throughout the U.S.A. should not want Data Centers is if they want to end up being backwards and poor. If they want to be successful and rich, with far lower taxes and jobs all over the place, let Data Reign. The good news is that there are plenty of other places that want them. If we kill the Golden Goose, you will only have yourselves to blame. China could not be happier with this anti Data Center movement. Actually, they can't believe it is happening! President DJT."

8/12 13:00

Cencora Sees FY26 Adjusted EPS of $17.75-$17.95

Cencora still sees FY26 adjusted EPS $17.75-$17.95, consensus $17.86

8/12 13:00

Cencora Reaffirms FY2026 EPS Guidance of $17.75 to $17.95

Cencora disclosed that beginning July 1, certain Walgreens volume that was being serviced by Cencora separate from the prime vendor agreement began moving outside the company. "The prime vendor agreement, which remains unchanged, constitutes the vast majority of the Company's business with Walgreens," the company added. This was fully contemplated in Cencora's commentary on Q4 expectations for its U.S. healthcare solutions segment. As such, Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.75 to $17.95 for fiscal 2026. Cencora shares are down 5% to $318.11 in midday trading.

6/15 16:30

Cencora HR Executive Announces Retirement

Cencora "announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer, has announced she will retire from the company following a distinguished seven-year tenure. She will be succeeded by Samantha Hammock, who will join Cencora as Executive Vice President and CHRO, effective July 13, 2026."

Show More Events

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.